阿尔茨海默病中的细胞:关键参与者和治疗点
相关实验视频
Updated: Jun 25, 2025

06:49
A High Output Method to Isolate Cerebral Pericytes from Mouse
Published on: January 14, 2020
8.4K
Yu Zhang1, Ben-Rong Mu1, Zhao Ran1
1Chongqing Key Laboratory of Sichuan-Chongqing Co-construction for Diagnosis and Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Experimental neurology
|May 22, 2024
概括
细胞是参与阿尔茨海默病 (AD) 病理学的关键脑细胞. 准这些细胞为AD治疗提供了有前途的新疗法策略.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特点是认知能力下降.
- 细胞对于脑血管功能和神经血管单元完整性至关重要,越来越多地涉及AD的病原性.
- 了解皮质细胞的作用对于开发有效的AD疗法至关重要.
研究的目的:
- 提供关于细胞周围细胞生物学及其在阿尔茨海默病中的具体参与的全面审查.
- 探索连接皮质细胞与AD病理学的机制,包括与关键分子和途径的相互作用.
- 突出针对心细胞治疗阿尔茨海默氏病的治疗潜力.
主要方法:
- 文献综述综合了当前关于中枢神经系统和AD中心细胞的研究.
- 对细胞与粉样β和阿波利波蛋白E相互作用的分析.
- 检查涉及皮细胞的信号通路和治疗策略.
主要成果:
- 细胞在中枢神经系统中表现出各种功能,包括调节血液流动和屏障完整性.
- 细胞功能障碍和与β粉样蛋白相互作用的改变有助于AD病理.
- 干细胞治疗和向皮细胞的药物治疗显示了AD干预的潜力.
结论:
- 细胞在阿尔茨海默病的进展中发挥着关键作用,并代表着重要的治疗点.
- 需要进一步研究皮质细胞亚型,衰老效应和外体细胞机制.
- 准细胞周围细胞为未来的阿尔茨海默病研究和临床应用提供了一个有希望的途径.
相关概念视频
Alzheimer's Disease: Overview
465
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
465
Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180

